Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
Status:
Completed
Trial end date:
2020-12-17
Target enrollment:
Participant gender:
Summary
Alopecia areata is a medical condition, in which the hair falls out in patches. The hair can
fall out on the scalp or elsewhere on the face and body. Alopecia areata is an autoimmune
skin disease, which means that the immune system is recognizing the hair follicles as foreign
and attacking them, causing round patches of hair loss. It can progress to total scalp hair
loss (alopecia totalis) or complete body hair loss (alopecia universalis). The scalp is the
most commonly affected area, but the beard or any hair-bearing site can be affected alone or
together with the scalp. Alopecia areata occurs in males and females of all ages, and is a
highly unpredictable condition that tends to recur. Alopecia areata can cause significant
distress to both patients and their families. In this study, the aim is to assess the effects
of dupilumab in patients with alopecia areata.